ReviewFrontiers in neuroscience2025
A review of the application of intelligent sensing technology in the recognition and evaluation of facial paralysis.
Review in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Facial paralysis (FP), as a highly prevalent neurological dysfunction disease worldwide, has long faced challenges such as strong subjectivity in assessment and difficulty in quantifying therapeutic effects in its clinical diagnosis and treatment. Traditional scales rely on physicians' experience. Neuroelectrophysiological examinations are invasive, while imaging evaluations are costly. The rise of intelligent sensing technology provides a new path to break through these limitations. Intelligent sensing technology has significantly improved the accuracy of FP recognition and assessment through multi-modal data fusion and dynamic monitoring. Its clinical value is not only reflected in the improvement of diagnostic efficiency, but also in promoting a fundamental change in the diagnosis and treatment model of FP. The artificial intelligence-assisted analysis mainly focuses on using machine learning algorithms to conduct in-depth exploration and analysis of the surface electromyogram (sEMG) signals of patients with facial paralysis, the motion trajectory data obtained through three-dimensional (3D) motion capture, as well as the data from patients' self-assessment scales. This study systematically reviews the innovative applications of intelligent sensing technology in the recognition and evaluation of FP, focusing on three major technical directions: sEMG, 3D motion capture, and artificial intelligence assisted analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.